Latest Close
$15.33
News
JANX
Janux Therapeutics, Inc. News
This news view pulls recent coverage and headlines tied to JANX.
1y Change
-$10.63 (-40.95%)
Market Cap
$934,890,112.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
3 Small-Cap Biotech Stocks Pairing Rapid Revenue Growth With High Insider Ownership
Simply Wall St. • Jul 24, 2026
Read articleIs Janux Therapeutics’ (JANX) Russell Index Exit Quietly Rewriting Its Investor Base and Story?
Simply Wall St. • Jul 9, 2026
Read articleVERAXA Biotech Stock in Focus as Lead Cancer Program Reaches Development Milestone
Exec Edge • Jul 2, 2026
Read articleIs Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential?
Insider Monkey • Jun 30, 2026
Read articleAkari Therapeutics Highlights 1st ASCO Abstract Acceptance
IPO-Edge.com • May 28, 2026
Read articleVERAXA Biotech Secures $27.5M Financing, to Go Public Via SPAC
Exec Edge • May 28, 2026
Read article